Lumosa Therapeutics Co., Ltd. (TPEX:6535)
70.20
+0.30 (0.43%)
Nov 6, 2026, 1:30 PM CST
| Market Cap | 11.76B -65.4% |
| Revenue (ttm) | 34.37M -7.7% |
| Net Income | -370.06M |
| EPS | -2.23 |
| Shares Out | 167.49M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 209,545 |
| Open | 63.30 |
| Previous Close | 69.90 |
| Day's Range | 63.30 - 72.20 |
| 52-Week Range | 63.30 - 222.00 |
| Beta | 0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 10, 2026 |